ClinicalTrials.gg
RecruitingNCT07839949Updated Sep 24, 2026

Dynamic Non-invasive Monitoring of Inspiratory Effort

An observational study in Respiratory Mechanics, Monitoring, Physiologic and Respiratory Insufficiency Requiring Mechanical Ventilation, sponsored by Fundació d'investigació Sanitària de les Illes Balears. Recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Fundació d'investigació Sanitària de les Illes Balears · Observational

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Sex
All
01

Study summary

This prospective, observational cohort study aims to evaluate whether the dynamic monitoring of a patient's breathing effort can predict successful liberation from invasive mechanical ventilation. The study will include 120 patients who have undergone 36 hours or more of controlled mechanical ventilation and deep sedation. Patient monitoring will commence immediately upon their transition to an assisted spontaneous breathing mode with pressure support. Starting from this clinical milestone, the researchers will track the patients' longitudinal inspiratory effort daily through four specific variables: maximum occlusion pressure, muscle pressure index, flow index via visual waveform inspection, and diaphragmatic thickening fraction via ultrasound. Concurrently, ventilator safety parameters (plateau pressure, driving pressure, transpulmonary pressure, and compliance) will be recorded. The primary outcome is the time from PSV initiation to successful weaning (defined as 72 hours without ventilator support). Clinical events such as death or return to a controlled mode due to PSV failure will be statistically treated as competing risks. Secondary outcomes include the incidence of pneumonia, ICU-acquired weakness, delirium, mortality, and PSV failure. Data will be analyzed using multivariate joint modeling within a Bayesian framework.

02

Conditions studied

  • Respiratory Mechanics
  • Monitoring, Physiologic
  • Respiratory Insufficiency Requiring Mechanical Ventilation
  • Critical Illness

Browse trials for

Keywords

  • Mechanical ventilation weaning, inspiratory effort, monitoring, pressure support ventilation
03

In context

Critical Illness

1,780 studies on the registry are indexed under Critical Illness; 442 are open to participants now.

This study's planned enrollment of 120 is below the median of 140 across 814 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Fundació d'investigació Sanitària de les Illes Balears is the lead sponsor of 20 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients admitted to Intensive Care Unit who require invasive mechanical ventilation due to any cause with 36 hours or more with a controlled mode of mechanical ventilation and deep sedation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old or more.
  • Patients undergoing invasive mechanical ventilation for any cause under a controlled ventilation mode for more than 36 hours.
  • Attending physician's decision to initiate pressure support ventilation according to standard clinical practice.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy.
  • Degenerative neuromuscular disease (e.g., amyotrophic lateral sclerosis, congenital myopathies).
  • Air leak/fistula that prevents breathing-pause maneuvers.
  • Diaphragmatic paralysis.
  • Limitation of life-sustaining treatment in case of weaning failure.
  • Conditions preventing follow-up up to 72 hours after liberation from mechanical ventilation.
  • Use of neuromuscular blocking agents within the last 24 hours.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Target follow-up
28 Days
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Daily Inspiratory Effort: diaphragmatic thickening fraction.

    Non-invasive monitoring of patient inspiratory effort performed daily starting from the initiation of pressure support ventilation using diaphragmatic thickening fraction measured via ultrasound. Unit of measure: percentage (%).

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  2. Daily Inspiratory Effort: pressure muscle index

    Non-invasive monitoring of patient inspiratory effort performed daily starting from the initiation of pressure support ventilation using the pressure muscle index measured in the mechanical ventilator during an end-inspiratory occlusion maneuver. Unit of measure: centimeters of water

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  3. Daily Inspiratory Effort: maximum occlusion pressure

    Non-invasive monitoring of patient inspiratory effort performed daily starting from the initiation of pressure support ventilation using the maximum occlusion pressure measured in the mechanical ventilator during an end-espiratory occlusion maneuver. Unit of measure: centimeters of water

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  4. Daily Inspiratory Effort: flow index

    Non-invasive monitoring of patient inspiratory effort performed daily starting from the initiation of pressure support ventilation using a qualitative evaluation by analyzing the airway flow waveform on the mechanical ventilator. The profile is categorized daily as positive (presence of effort) or negative (absence of effort). For reporting and analytical purposes, this qualitative assessment is coded as a binary scale where 0 indicates a negative flow index and 1 indicates a positive flow index. Individual daily data trajectories will be analyzed using a Bayesian joint model. Unit of measure: score on a scale, where 0 represents negative flow index and 1 represents a positive flow index

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

Secondary outcomes

  1. incidence of Ventilator-Associated Pneumonia

    proportion of patients who develop ventilator-associated pneumonia based on standard clinical, radiological, and microbiological criteria.

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  2. incidence of Intensive Care Unit-Acquired Weakness

    development of critical illness weakness evaluated via the Medical Research Council score, which evaluates 6 muscle groups bilaterally, ranging from a total score of 0 (no strength) to 60 (normal muscle strength), where higher scores indicate better muscle strength. Intensive Care Unit-Acquired Weakness will be defined as an MRC sum score of 48 or less.

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  3. incidence of delirium

    daily screening for delirium using the Confusion Assessment Method for the Intensive Care Unit, which assesses four features: (1) acute onset or fluctuating course, (2) inattention, (3) altered level of consciousness, and (4) disorganized thinking. Delirium is defined as positive when features 1 and 2, and either feature 3 or 4 are present.

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  4. incidence of mortality

    incidence of death by any cause during the study period (handled as a competing risk in the main analysis).

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, return to a controlled ventilation mode for more than 6 hours, death or tracheostomy, assessed up to 28 days.

  5. Return to controlled mode of mechanical ventilation

    proportion of patients requiring a return to a controlled mechanical ventilation mode due to pressure support ventilation failure before achieving weaning

    Time frame: Measured daily from the initiation of pressure support ventilation until the occurrence of successful liberation from mechanical ventilation, death or tracheostomy, assessed up to 28 days.

07

Study locations

1 of 1 sites recruiting
  • Department of Intensive Care Medicine, Hospital Universitario Son Espases
    Palma de Mallorca, Balearic Islands 07120, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — individual participant data will not be share outside the core research team to ensure strict patient confidentiality and comply with local data protection regulations

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07839949
Lead sponsor
Fundació d'investigació Sanitària de les Illes Balears
Responsible party
Jacinto Espeleta Hernández (Attending physician of critical care medicine, Fundació d'investigació Sanitària de les Illes Balears) — Principal investigator
First posted
Sep 24, 2026
Start date
Aug 4, 2026
Primary completion
Aug 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Jacinto Espeleta Hernández, MD
Contact
jacinto.espeleta@ssib.es
+34685814532
Jacinto Espeleta Hernández, MD
principal investigator · Hospital Son Espases

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion